Anergis SA of Switzerland has provided further data on its lead vaccine for birch pollen allergy which showed that the treatment increased allergen-specific antibody levels by a factor of 20, indicating an immunological response. ---Subscribe to MedNous to access this article--- Company News Clinical Research
